# FDA Inspection 1303042 - TriForLife, LLC - January 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/triforlife-llc/583d79f3-0ec7-40c9-9c3a-5258154d881a
Source feed: FDA_Inspections

> FDA Inspection 1303042 for TriForLife, LLC on January 16, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303042
- Company Name: TriForLife, LLC
- Inspection Date: 2026-01-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics

## Related Documents

- [FDA Inspection 1303042 - 2026-01-16](https://www.keypedia.com/records/fda_inspections/triforlife-llc/e33dc121-d19a-41b1-b202-594503cb4c54)
- [FDA Inspection 1221394 - 2023-09-11](https://www.keypedia.com/records/fda_inspections/triforlife-llc/37c76948-aa36-4b2a-b082-21afe96895a6)

Company: https://www.keypedia.com/companies/triforlife-llc/00b57271-f28c-4d9e-b0e4-9b40d9b9777f